Global Health (MEDANTA) Share Price Falls 2.22% as MEDANTA Declines
- September 21, 2026
- Posted by: Harsh Piplani
- Category: News
Global Health Share Price moved lower to Rs 1,473.25 on 21 September 2026, after a 2.22% decline from the previous close of Rs 1,506.75. The company, which has a market capitalisation of Rs 40,512.26 crore and is classified as a Large Cap, is in focus because the day’s decline occurred without a verified company-specific catalyst in the supplied data. MEDANTA Stock News therefore centres on what the price action shows, how the valuation compares with healthcare peers, and what the available fundamentals indicate. For readers tracking Global Health Share Price Today, Univest places the move in context against sector benchmarks and listed peers rather than speculation. In simple terms, the supplied data confirms the fall, the day’s range and the valuation backdrop, but does not establish a company-specific trigger for why Global Health Share Price softened.
MEDANTA opened at Rs 1,400.90, matched the day’s low at Rs 1,400.90, and touched Rs 1,517.20 at the day’s high. The stock finished Rs 33.50 below the previous close, and turnover stood at Rs 1.2 crore. With that, the key question for Global Health Stock News is not only what changed in price, but also how the current valuation, profitability and healthcare sector comparison shape the discussion around the Global Health Share Price Fall.
Global Health (MEDANTA) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,473.25 |
| Previous Close | Rs 1,506.75 |
| Today's Move | -Rs 33.50 (-2.22%) |
| Open | Rs 1,400.9 |
| High | Rs 1,517.2 |
| Low | Rs 1,400.9 |
| Turnover | Rs 1.2 crore |
| Market Capitalisation | Rs 40,512.26 crore |
| Market Cap Category | Large Cap |
Global Health Share Price Today settled at Rs 1,473.25, compared with the previous close of Rs 1,506.75. That is a day change of Rs -33.50, or -2.22%, and the move places MEDANTA among the stocks being closely followed in today’s market update. The session began at Rs 1,400.90, which also marked the day’s low, while the stock briefly reached Rs 1,517.20 before easing back. This gives a clear intraday range to assess: the low at Rs 1,400.90 and the high at Rs 1,517.20 bracket the day’s price action. Turnover was Rs 1.2 crore, which is a factual traded-value figure and not a reason for the decline. Because the workflow has categorised the company as a Large Cap, the fall is being read in the context of a sizeable listed healthcare business rather than a smaller company. The event matters because it shows a same-day share price fall, but the supplied data does not establish a company-specific catalyst. For investors tracking Global Health Share Price Live, the next step is to place the move alongside valuation and sector comparisons rather than treating the decline as a standalone signal.
Global Health (MEDANTA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 40,512.26 crore |
| P/E Ratio | 72.84x |
| P/B Ratio | 9.85x |
| ROE | 15.12% |
| ROCE | 19.38% |
| EPS | Rs 20.69 |
| Book Value Per Share | Rs 152.92 |
| Dividend Yield | 0.03% |
Global Health Share Price must be viewed against a market capitalisation of Rs 40,512.26 crore, a P/E ratio of 72.84 and a P/B ratio of 9.85. Those numbers indicate that the stock is priced at a meaningfully richer valuation than many healthcare peers on an earnings basis, while the book-value multiple is also elevated. The company’s ROE is 15.12% and ROCE is 19.38%, which show solid returns on equity and capital employed in absolute terms. EPS stands at Rs 20.69, book value per share is Rs 152.92 and dividend yield is 0.03%, so the share price is carrying a high earnings multiple relative to current per-share earnings while the payout yield remains minimal. For readers studying Global Health Fundamental Analysis, the important point is that the available metrics support a premium valuation conversation, not a direction call. The fall in Global Health Share Price Today therefore sits against a backdrop of strong reported profitability ratios, a low dividend yield and a large company base. Univest readers often use this stage to separate the day’s price move from the company’s longer-term financial profile. In MEDANTA Stock News, that distinction is especially relevant because the supplied data confirms the decline but does not assign a catalyst.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Hospital & Healthcare Services |
| Benchmark Scope | same industry |
| Company P/E Ratio | 72.84x |
| Benchmark Median P/E | 48.32x |
| Benchmark Average P/E | 102.51x |
| Benchmark P/E Range | 6.96x to 1,595.77x |
| Company P/B Ratio | 9.85x |
| Benchmark Median P/B | 3.24x |
| Benchmark Average P/B | 4.25x |
| Company ROE | 15.12% |
| Benchmark Median ROE | 13.01% |
| Benchmark Average ROE | 13.56% |
| Company ROCE | 19.38% |
| Benchmark Median ROCE | 15.84% |
| Benchmark Average ROCE | 3.87% |
| Company Market Capitalisation | Rs 40,512.26 crore |
| Benchmark Median Market Cap | Rs 495.03 crore |
| Benchmark Average Market Cap | Rs 11,301.17 crore |
Global Health operates in the Healthcare sector and the Hospital & Healthcare Services industry, where the supplied benchmark covers 67 companies in the same industry. On the benchmark set, the company’s P/E of 72.84 is above the peer median of 48.32 and below the peer average of 102.51. Its P/B of 9.85 is also above the peer median of 3.24 and above the peer average of 4.25. ROE at 15.12% is above the peer median of 13.01% and above the peer average of 13.56%, while ROCE at 19.38% is above the peer median of 15.84%. Market capitalisation at Rs 40,512.26 crore is far above the benchmark median of Rs 495.03 crore and below the benchmark maximum of Rs 1,26,102.74 crore. This combination shows that Global Health Share Price is being assessed in a large-company healthcare context where valuation remains premium relative to the industry middle, but profitability ratios are also stronger than the benchmark centre. The sector data does not explain the day’s fall; instead, it gives the lens through which MEDANTA Stock News should be interpreted. For Global Health Share Price Today, the sector comparison is useful because it separates the intraday decline from the broader valuation and return profile.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Apollo Hospitals Enterprise | APOLLOHOSP | 1,26,102.74 | 60.35 | 13.02 | 23.54 | 21.73 |
| Max Healthcare Institute | MAXHEALTH | 1,02,684.23 | 70.48 | 9.4 | 14.53 | 14.97 |
| MANIPAL HEALTH ENTERPRI L | MANIPALHOS | 97,127.45 | 108.85 | 5.32 | 12.95 | 13.93 |
| Fortis Healthcare | FORTIS | 66,058.84 | 63.04 | 6.5 | 11.32 | 14.07 |
| Aster DM Healthcare | ASTERDM | 65,885.36 | 206.74 | 15.58 | 13.07 | 16.22 |
Among listed healthcare peers, Global Health sits below Apollo Hospitals Enterprise on market capitalisation, and also below Max Healthcare Institute and MANIPAL HEALTH ENTERPRI L on size, while remaining above Fortis Healthcare and several other comparables in the supplied set. On valuation, Global Health ’s P/E of 72.84 is higher than Apollo Hospitals at 60.35 and Fortis at 63.04, but below Aster DM Healthcare at 206.74 and MANIPAL HEALTH ENTERPRI L at 108.85. Its P/B of 9.85 is below Apollo Hospitals at 13.02 and Aster DM Healthcare at 15.58, while above Max Healthcare at 9.4 and Fortis at 6.5. On profitability, ROE of 15.12% sits below Apollo Hospitals at 23.54% and Dr. Lal Pathlabs at 22.37%, but above Max Healthcare at 14.53% and Fortis at 11.32%. ROCE of 19.38% is ahead of Max Healthcare at 14.97% and Fortis at 14.07%, but below Apollo Hospitals at 21.73% and Dr. Lal Pathlabs at 29.56%. For Global Health Share Price analysis, the peer set shows a company with stronger returns than some peers but a valuation that still looks premium in the healthcare universe.
Why Investors Are Watching Global Health
- Global Health Share Price fell 2.22% to Rs 1,473.25 from the previous close of Rs 1,506.75.
- The day’s range spanned Rs 1,400.90 to Rs 1,517.20, showing the full intraday movement in MEDANTA Share Price Today.
- Market capitalisation stands at Rs 40,512.26 crore, and the market-cap category supplied is Large Cap.
- The company’s P/E ratio is 72.84, P/B ratio is 9.85, ROE is 15.12% and ROCE is 19.38%.
- Healthcare peer context places Global Health above the benchmark median on P/E and P/B, while returns remain above benchmark medians.
About Global Health
Global Health is classified in the Healthcare sector and the Hospital & Healthcare Services industry. The supplied company data centres on its listed identity as MEDANTA, its market capitalisation and its valuation and return ratios. In this article, Global Health Stock News is viewed strictly through the verified market data supplied by the workflow: share price, market cap, valuation multiples, profitability measures and peer context. For readers scanning Global Health Share News or MEDANTA Company News, the most relevant verified point is that today’s price move is a same-day decline rather than a company-description event, and the financial framing comes from the supplied numbers. Univest uses this type of article to connect the day’s move with the company’s published market profile without adding assumptions.
Track Global Health Share Price on Univest
Use Global Health (MEDANTA) live share-price page,Univest top decliners screener,Univest market blogs to review live stock data, top decliners and related market analysis.
You can track Global Health Share Price on Univest for live price updates, valuation ratios, shareholding pattern, 52-week levels and market insights. The platform also helps readers review Global Health Stock Analysis, Global Health Share Price Update and broader market context in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is Global Health Share Price falling today?
Ans. The supplied data confirms a 2.22% fall in Global Health Share Price to Rs 1,473.25, but it does not establish a company-specific catalyst. The session also showed Rs 1,400.90 as the low and Rs 1,517.20 as the high.
What is Global Health Share Price Today?
Ans. Global Health Share Price Today is Rs 1,473.25. It is down Rs 33.50 from the previous close of Rs 1,506.75, and the stock is being tracked as part of today’s healthcare market update.
What is the market capitalisation of Global Health?
Ans. Global Health has a market capitalisation of Rs 40,512.26 crore and is classified as a Large Cap. That size context is factual and should be read alongside its valuation, profitability and peer comparisons.
How does Global Health compare with healthcare peers?
Ans. Global Health Share Price sits in a healthcare peer set where its P/E of 72.84 is above the benchmark median of 48.32, while ROE of 15.12% and ROCE of 19.38% are also above benchmark medians.
What do Global Health valuation metrics show?
Ans. The company’s P/E is 72.84, P/B is 9.85, EPS is Rs 20.69 and book value is Rs 152.92. These figures show a premium valuation profile relative to the industry median, alongside positive return ratios.
Does Global Health pay a dividend?
Ans. The supplied dividend yield for Global Health is 0.03%. That is a historical or current yield figure, not a guarantee of future payout, and it should be viewed with the rest of the company’s financial data.
